Tema Neuroscience and Mental Health ETF

Rentabilität für sechs Monate: -9.47%
Industrie: Health & Biotech Equities

Vertex
Regeneron
Eli Lilly and Company
argenx SE
Denali Therapeutics Inc.
Alnylam Pharmaceuticals, Inc.
Neurocrine Biosciences
Teva Pharmaceutical Industries
Biogen
United Community Banks, Inc.
Ausruhen
Vertex: 6.2%Regeneron: 5.7%Eli Lilly and Company: 5.6%argenx SE: 4.8%Denali Therapeutics Inc.: 4.4%Alnylam Pharmaceuticals, Inc.: 4.1%Neurocrine Biosciences: 4.1%Teva Pharmaceutical Industries: 4%Biogen: 3.8%United Community Banks, Inc.: 3.5%Ausruhen: 53.8%Anteil nach Unternehmen teilende.porti.ru
SVG speichern
PNG speichern
CSV speichern
NameIndustrieAktie, %P/BVP/SP/EEV/EbitdaDividendenrendite
Vertex Vertex Healthcare 6.21945 6 10.73 29.17 24.42 0
Regeneron Regeneron Healthcare 5.73067 3.71 7.34 24.35 23.78 0.1388
Eli Lilly and Company Eli Lilly and Company Healthcare 5.62532 47.43 15.1 98.32 43.16 0.5892
argenx SE argenx SE Healthcare 4.79415 5.2 17.38 0 -87.37 0
Denali Therapeutics Inc. Denali Therapeutics Inc. Healthcare 4.3974 2.93 9.13 62.94 -16.35 0
Alnylam Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. Healthcare 4.10467 -108.14 13.05 0 -112.79 0
Neurocrine Biosciences Neurocrine Biosciences Healthcare 4.06159 5.81 6.87 51.96 31.6 0
Teva Pharmaceutical Industries Teva Pharmaceutical Industries Healthcare 4.02476 1.44 1.55 872 66.18 0
Biogen Biogen Healthcare 3.81556 2.54 2.26 13.43 16.87 0
United Community Banks, Inc. Financials 3.47423 0.1293 4 18.6 10.12 3.39
46.24-3.38.74117.08-0.040.41

Bezahlen Sie Ihr Abonnement

Weitere Funktionen und Daten zur Unternehmens- und Portfolioanalyse sind im Abonnement verfügbar